Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa(C) Gene in Streptococcus agalactiae UCN70

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1470-1474

  Malbruny, Brigitte ^a   Werno, Anja M ^b   Murdoch, David R ^b   Leclercq, Roland ^a   Cattoir, Vincent ^a  

^a CHU CÔTE DE NACRE   (France)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AZITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; LINCOMYCIN; LINCOSAMIDE; PLEUROMUTILIN; QUINUPRISTIN; SPIRAMYCIN; TELITHROMYCIN; TIAMULIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; CONTROLLED STUDY; CROSS RESISTANCE; ENTEROCOCCUS FAECALIS; GENE EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NEW ZEALAND; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DITERPENES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; LINCOSAMIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; STREPTOCOCCUS AGALACTIAE; STREPTOGRAMINS;

EID: 79953221474     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01068-10     Document Type: Article

References (28)

1. Andersen, C. B., et al. 2006. Structure of eEF3 and the mechanism of transfer RNA release from the E-site. Nature 443:663-668. (Pubitemid 44564704)
2. Brzychczy-Wloch, M., et al. 2010. Genetic characterization and diversity of Streptococcus agalactiae isolates with macrolide resistance. J. Med. Microbiol. 59:780-786.
3. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; approved standard, 19th ed. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Davidson, A. L., E. Dassa, C. Orelle, and J. Chen. 2008. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol. Mol. Biol. Rev. 72:317-364.
5. Domelier, A. S., et al. 2008. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J. Antimicrob. Chemother. 62:1227-1233.
6. Fluegge, K., S. Supper, A. Siedler, and R. Berner. 2004. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob. Agents Chemother. 48:4444-4446.
7. Gentry, D. R., et al. 2008. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. Antimicrob. Agents Chemother. 52:4507-4509.
8. Gygax, S. E., et al. 2006. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob. Agents Chemother. 50:1875-1877.
9. Horodniceanu, T., L. Bougueleret, N. El-Solh, D. H. Bouanchaud, and Y. A. Chabbert. 1979. Conjugative R plasmids in Streptococcus agalactiae (group B). Plasmid 2:197-206.
10. Kadlec, K., and S. Schwarz. 2009. Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain. Antimicrob. Agents Chemother. 53:3589-3591.
11. Kehrenberg, C., K. K. Ojo, and S. Schwarz. 2004. Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri. J. Antimicrob. Chemother. 54:936-939.
12. Ko, W. C., et al. 2001. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 20:334-339.
13. Kos, V., and R. C. Ford. 2009. The ATP-binding cassette family: a structural perspective. Cell. Mol. Life Sci. 66:3111-3126.
14. Larsen, J. W., and J. L. Sever. 2008. Group B Streptococcus and pregnancy: a review. Am. J. Obstet. Gynecol. 198:440-448.
15. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
16. Malbruny, B., A. M. Werno, T. P. Anderson, D. R. Murdoch, and R. Leclercq. 2004. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J. Antimicrob. Chemother. 54:1040-1044.
17. Novak, R., and D. M. Shlaes. 2010. The pleuromutilin antibiotics: a new class for human use. Curr. Opin. Invest. Drugs 11:182-191.
18. Novotna, G., and J. Janata. 2006. A new evolutionary variant of the streptogramin A resistance protein, Vga(A)LC, from Staphylococcus haemolyticus with shifted substrate specificity towards lincosamides. Antimicrob. Agents Chemother. 50:4070-4076.
19. Reynolds, E., J. I. Ross, and J. H. Cove. 2003. Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters? Int. J. Antimicrob. Agents 22:228-236.
20. Ross, J. I., et al. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:1207-1214.
21. Schrag, S., R. Gorwitz, K. Fultz-Butts, and A. Schuchat. 2002. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm. Rep. 51:1-22.
22. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
23. Sendi, P., L. Johansson, and A. Norrby-Teglund. 2008. Invasive group B streptococcal disease in non-pregnant adults: a review with emphasis on skin and soft-tissue infections. Infection 36:100-111.
24. Singh, K. V., G. M. Weinstock, and B. E. Murray. 2002. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob. Agents Chemother. 46:1845-1850.
25. Trieu-Cuot, P., C. Carlier, C. Poyart-Salmeron, and P. Courvalin. 1990. A pair of mobilizable shuttle vectors conferring resistance to spectinomycin for molecular cloning in Escherichia coli and in gram-positive bacteria. Nucleic Acids Res. 18:4296. (Pubitemid 20240267)
26. Werno, A. M., T. P. Anderson, and D. R. Murdoch. 2003. Antimicrobial susceptibilities of group B streptococci in New Zealand. Antimicrob. Agents Chemother. 47:2710-2711.
27. Wu, J. J., et al. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:844-846.
28. Xu, J., et al. 2006. Molecular localization of a ribosome-dependent ATPase on Escherichia coli ribosomes. Nucleic Acids Res. 34:1158-1165.